Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Prepaid Assets of $29.7 million for Q1 2026, down 30.27% on a QoQ basis from $42.6 million in Q4 2025, and up 16.83% year-over-year from $25.4 million in Q1 2025.
Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International's Prepaid Assets history runs 10 years deep, the most recent figure standing at $29.7 million for Q1 2026.
- Quarterly Prepaid Assets rose 16.83% year-over-year to $29.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.7 million (up 16.83% YoY) and the FY2025 annual result came in at $42.6 million, up 112.18% from the prior year.
- Prepaid Assets was $29.7 million for Q1 2026 at Kiniksa Pharmaceuticals International, down from $42.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $42.6 million in Q4 2025 and bottomed at $10.5 million in Q1 2022.
- A 5-year average of $22.1 million and a median of $20.1 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets fell 11.18% — and 2024, when it soared 116.67%.
- Kiniksa Pharmaceuticals International's Prepaid Assets stood at $10.5 million in 2022, then jumped by 66.44% to $17.5 million in 2023, then increased by 14.52% to $20.1 million in 2024, then soared by 112.18% to $42.6 million in 2025, then plunged by 30.27% to $29.7 million in 2026.
- Business Quant data shows KNSA's Prepaid Assets at $29.7 million in Q1 2026, $42.6 million in Q4 2025, and $30.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.71 Mn |
| Dec 31, 2025 | 42.61 Mn |
| Sep 30, 2025 | 30.29 Mn |
| Jun 30, 2025 | 32.44 Mn |
| Mar 31, 2025 | 25.43 Mn |
| Dec 31, 2024 | 20.08 Mn |
| Sep 30, 2024 | 33.95 Mn |
| Jun 30, 2024 | 26.95 Mn |
| Mar 31, 2024 | 13.77 Mn |
| Dec 31, 2023 | 17.54 Mn |
| Sep 30, 2023 | 26.40 Mn |
| Jun 30, 2023 | 12.44 Mn |
| Mar 31, 2023 | 13.16 Mn |
| Dec 31, 2022 | 10.54 Mn |
| Sep 30, 2022 | 15.31 Mn |
| Jun 30, 2022 | 14.01 Mn |
| Mar 31, 2022 | 10.52 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 8.50 Mn |
| Jun 30, 2021 | 9.80 Mn |